Contact FreedomWorks

111 K Street NE
Suite 600
Washington, DC 20002

  • Toll Free 1.888.564.6273
  • Local 202.783.3870
WATCH NOWDeSantis Explodes, Wolf Implodes, & Hawley's Dumpster Fire Bill | Pardon The DisruptionWatch Here
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/HHSvideo.png?itok=hu5Fr_xu
Press Release

FreedomWorks Urges HHS to Wash its Hands of Prescription Drug Price Controls Proposal

WASHINGTON, D.C. -- in opposition to The Department of Health and Human Services’ (HHS) proposal to institute price controls on prescription drugs, FreedomWorks distributed hand sanitizer to employees and passerby outside of the Washington, DC HHS headquarters, urging Sec. Azar’s HHS to “wash its hands of the price controls.” A link to the video can be found by clicking on the image below.

02/25/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Op-ed Placement

Their Support for Price Controls Confirms Republicans Are Dems Following Speed Limit

BY Daniel Savickas

Libertarian author and media personality Michael Malice has a saying that goes something along these lines, “Conservatives are just progressives driving the speed limit.” It is one of the more prescient observations in modern politics today. Republican politicians who self-describe as conservatives will eventually come to the same conclusions as progressive Democrats, just a little bit later.

12/11/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Press Release

FreedomWorks Statement in Response to Nancy Pelosi’s Drug Price Control Proposal

WASHINGTON, D.C. -- In response to Speaker Nancy Pelosi (D-Calif.) rolling out her drug pricing proposal, which includes price controls, Adam Brandon, FreedomWorks President, commented:

09/19/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/650x350_valsartan_recall_community.jpg?itok=jAjnFY9h
Blog

Removing the Last Remnants of the Free Market from Medicare

Created in 2003 as part of the Medicare Modernization Act, Part D of Medicare was designed to provide financial aid for prescription medication purchases of Medicare beneficiaries. As of 2018, 43 million people receive prescription drug coverage under Part D; 58% of those are on a stand-alone prescription drug plan, as opposed to the Medicare Advantage plans that provide supplementary coverage. Though is is open to all Americans who receive Part A and/or Part B benefits, Part D is an entirely optional program.

08/22/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/FW-DumpsterFireOfTheMonth-FBLink_1_1_0.png?itok=lazOnmno
Blog

FreedomWorks' Dumpster Fire of the Month for June 2019: The Transparent Drug Pricing Act, S. 977

FreedomWorks’ activist-chosen dumpster fire of the month for May 2019 is the Transparent Drug Pricing Act, S. 977. Introduced by Rep. Rick Scott (R-FL), this is yet another proposal targeted at reducing prescription drug prices in America based on the faulty logic of international price controls. Among other substantive changes to public health regulations, S. 977 would mandate that U.S. prescription drug prices “may not exceed the lowest retail list price for the drug among Canada, France, the United Kingdom, Japan, or Germany.”

06/21/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/PillBottle_0.jpg?itok=oA8jA0G3
Issue Analysis

By Any Other Name: Price Controls are Price Controls

Many conservatives and right-of-center political analysts are rightly upset about Health and Human Service Secretary Alex Azar’s proposal to tie drug prices in the United States to those in foreign nations. Such a proposal would make our healthcare system dependent on the whims of nations that subscribe to command and control economic models. There is also the stark reality that imposing price controls does not fix any underlying issues that caused prices to be high in the first place.

06/10/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/PBM_Illustration.jpg?itok=0H_Cupjb
Blog

FreedomWorks' Bill of the Month for June 2019: The Prescription Drug Price Transparency Act, H.R. 1035

FreedomWorks is proud to announce that our bill of the month for June 2019 is the Prescription Drug Price Transparency Act, H.R. 1035, sponsored by Rep. Doug Collins (R-Ga.). The Prescription Drug Price Transparency Act would require greater transparency and accountability from pharmacy benefit managers (PBMs). This would lower prices for patients, families, and caregivers across the United States.

06/06/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/Drug_Moneys.jpg?itok=5xFumk84
Issue Analysis

Drug Price Controls are Dangerous to Your Health

Almost all Americans want lower price prescription drugs, and it is indefensible that American consumers often have to pay higher prices than customers in developed nations around the world. This is especially intolerable given that most of the wonder drugs of recent years and decades that we pay more for have been developed on these shores.

05/28/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/Washington-Times-Logo-02_1.png?itok=oiq9y64c
Op-ed Placement

Resisting Price Controls on Prescription Drugs

BY Adam Brandon

President Trump has made great strides in dismantling the big-government legacy of his predecessor, Barack Obama. Historic tax cuts, dozens of regulations cut for every new one implemented, and two conservative Supreme Court justices, to name a few.

05/17/2019
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/FW_Illegal_Pricing_Index_Blog_Photo01.jpg?itok=aAHsKhjn
Issue Analysis

The Illegal Pricing Index

The small area of sanity in our healthcare sector is now under threat, however. A new proposal by the Department of Health and Human Services (HHS), referred to as the International Pricing Index (IPI), would dramatically undermine American leadership in pharmaceutical innovation and risk patient access to life-changing and life-saving treatments.

05/16/2019

Pages